Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George M Solomon

Showing results (21-30 of 86) with videos related to

Pageof 9
Sort By:
Medical Research Archives|July 2, 2026
Effects of High Frequency Chest Wall Oscillation (HFCWO) on Clinical Symptoms in Chronic Obstructive Lung DiseaseMeaghan M Bruner, Clarissa Bazan, Bo Liu, et al.
Plos One|August 27, 2013
IP-10 is a potential biomarker of cystic fibrosis acute pulmonary exacerbationsGeorge M Solomon, Carla Frederick, Shaoyan Zhang, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|November 30, 2025
Elexacaftor/tezacaftor/ivacaftor is associated with long-term reduction in use of chronic respiratory therapies in cystic fibrosisScott D Sagel, Phuong Vu, Sonya L Heltshe, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|April 25, 2018
Effectiveness of ivacaftor in cystic fibrosis patients with non-G551D gating mutationsJennifer Guimbellot, George M Solomon, Arthur Baines, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 21, 2021
Patient and family experience of telehealth care delivery as part of the CF chronic care model early in the COVID-19 pandemicGeorge M Solomon, Julianna Bailey, James Lawlor, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|March 2, 2018
Seeing cilia: imaging modalities for ciliary motion and clinical connectionsJacelyn E Peabody, Ren-Jay Shei, Brent M Bermingham, et al.
The Lancet. Respiratory Medicine|May 18, 2016
Pilot evaluation of ivacaftor for chronic bronchitisGeorge M Solomon, Heather Hathorne, Bo Liu, et al.
The Pediatric Infectious Disease Journal|October 1, 2019
Area Deprivation as a Risk Factor for Methicillin-resistant Staphylococcus aureus Infection in Pediatric Cystic FibrosisGabriela R Oates, William T Harris, Steven M Rowe, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 23, 2020
Elexacafator/tezacaftor/ivacaftor resolves subfertility in females with CF: A two center case seriesKate E O'Connor, Dana L Goodwin, Andrew NeSmith, et al.
The Journal of Clinical Investigation|September 5, 2024
Elexacaftor/tezacaftor/ivacaftor's effects on cystic fibrosis infections are maintained, but not increased, after 3.5 years of treatmentSarah J Morgan, Ellis Coulter, Hannah L Betts, et al.
Pageof 9

Showing results (21-30 of 86) with videos related to

Sort By:
Pageof 9
Medical Research Archives|July 2, 2026
Effects of High Frequency Chest Wall Oscillation (HFCWO) on Clinical Symptoms in Chronic Obstructive Lung DiseaseMeaghan M Bruner, Clarissa Bazan, Bo Liu, et al.
Plos One|August 27, 2013
IP-10 is a potential biomarker of cystic fibrosis acute pulmonary exacerbationsGeorge M Solomon, Carla Frederick, Shaoyan Zhang, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|November 30, 2025
Elexacaftor/tezacaftor/ivacaftor is associated with long-term reduction in use of chronic respiratory therapies in cystic fibrosisScott D Sagel, Phuong Vu, Sonya L Heltshe, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|April 25, 2018
Effectiveness of ivacaftor in cystic fibrosis patients with non-G551D gating mutationsJennifer Guimbellot, George M Solomon, Arthur Baines, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 21, 2021
Patient and family experience of telehealth care delivery as part of the CF chronic care model early in the COVID-19 pandemicGeorge M Solomon, Julianna Bailey, James Lawlor, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|March 2, 2018
Seeing cilia: imaging modalities for ciliary motion and clinical connectionsJacelyn E Peabody, Ren-Jay Shei, Brent M Bermingham, et al.
The Lancet. Respiratory Medicine|May 18, 2016
Pilot evaluation of ivacaftor for chronic bronchitisGeorge M Solomon, Heather Hathorne, Bo Liu, et al.
The Pediatric Infectious Disease Journal|October 1, 2019
Area Deprivation as a Risk Factor for Methicillin-resistant Staphylococcus aureus Infection in Pediatric Cystic FibrosisGabriela R Oates, William T Harris, Steven M Rowe, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 23, 2020
Elexacafator/tezacaftor/ivacaftor resolves subfertility in females with CF: A two center case seriesKate E O'Connor, Dana L Goodwin, Andrew NeSmith, et al.
The Journal of Clinical Investigation|September 5, 2024
Elexacaftor/tezacaftor/ivacaftor's effects on cystic fibrosis infections are maintained, but not increased, after 3.5 years of treatmentSarah J Morgan, Ellis Coulter, Hannah L Betts, et al.
Pageof 9